Is Costco Stock Worth Its Hefty Price Tag?

NASDAQ: COST | Costco Wholesale Corporation News, Ratings, and Charts

COST – Costco Wholesale (COST) is currently trading just 10.9% below its 52-week high and possesses further upside potential, according to Wall Street. The stock closed the last trading session at $545.75. However, is it worth investing in COST at this hefty price level? Let’s find out….

Retail giant Costco Wholesale Corporation (COST) and its subsidiaries operate membership warehouses in the United States, Puerto Rico, Canada, the United Kingdom, Mexico, Japan, Korea, Australia, Spain, France, Iceland, China, and Taiwan. It offers branded and private-label products in a range of merchandise categories.

On June 30, 2022, COST completed a purchase for $1.05 billion by a wholly-owned subsidiary of the 45% minority interest in Costco-Taiwan- a joint venture.

COST has lost 3.9% year-to-date to close the last trading session at $545.75. However, it has gained 21.9% over the past year and 4.4% over the past month. The stock is currently trading 10.9% below its 52-week high of $612.27, which it hit on April 7, 2022.

Here is what could shape COST’s performance in the near term:

Retail and Grocery Sales Rise Despite Soaring Inflation

Despite decades-high inflation, retails and grocery sales remained robust. According to Mastercard SpendingPulseTM, U.S. retail spending excluding automotive increased 11.2% year-over-year in July, while e-commerce sales were up 11.7% year-over-year.

On the other hand, online grocery sales surged 8.3% to $7.80 billion in July. In addition, COST reported net sales of $16.85 billion for the month of July, up 10.8% year-over-year.

Solid Financials

COST’s total revenue came in at $52.60 billion for the third quarter ended May 8, 2022, up 16.2% year-over-year. Its net sales came in at $51.61 billion, up 16.3% year-over-year. Also, its operating income came in at $1.79 billion, up 7.7% year-over-year.

Furthermore, its net income came in at $1.35 billion, up 10.9% year-over-year, while its EPS came in at $3.04, up 10.5% year-over-year. 

Favorable Analyst Expectations

Analysts expect COST’s revenue to increase 15.5% year-over-year in 2022 and 8.6% year-over-year in 2023. Its EPS is expected to increase 17.9% year-over-year in 2022 and 11.1% year-over-year in 2023. The stock has surpassed EPS estimates in each of the trailing four quarters.

Of the 18 Wall Street analysts that have rated COST, 14 rated it Buy, while four rated it Hold. Moreover, Wall Street analysts expect the stock to hit $567.17 in the near term, indicating a potential upside of 3.9%.

POWR Ratings Reflect Promising Outlook

COST has an overall rating of B, which equates to Buy in our proprietary POWR Ratings system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.

It has a B grade for Growth, consistent with its solid financials in the latest reported quarter.

The stock also has a B grade for Sentiment, in sync with favorable analysts’ sentiments.

In the 38-stock Grocery/Big Box Retailers industry, COST is ranked #24. The industry is rated A.

Click here for the additional POWR Ratings for COST (Momentum, Stability, and Quality).

View all the top stocks in the Grocery/Big Box Retailers industry here.

Bottom Line

Despite the soaring inflation, retail spending remained robust, providing support to the company. Moreover, its revenue and EPS have increased at 13.3% and 16% CAGRs over the past three years. And analysts now expect its EPS to increase 13.7% per annum for the next five years. Considering COST’s solid fundamentals, I think its hefty price tag is well justified.

How Does Costco Wholesale Corporation (COST) Stack Up Against its Peers?

While COST has an overall POWR Rating of B, one might consider looking at its industry peers Ingles Markets, Incorporated (IMKTA), The Kroger Co. (KR), and Casey’s General Stores, Inc. (CASY), which have an overall A (Strong Buy) rating, and Sprouts Farmers Market, Inc. (SFM), which has an overall B (Buy) rating.


COST shares were trading at $550.97 per share on Tuesday morning, up $5.22 (+0.96%). Year-to-date, COST has declined -2.47%, versus a -9.25% rise in the benchmark S&P 500 index during the same period.


About the Author: Riddhima Chakraborty


Riddhima is a financial journalist with a passion for analyzing financial instruments. With a master's degree in economics, she helps investors make informed investment decisions through her insightful commentaries. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
COSTGet RatingGet RatingGet Rating
IMKTAGet RatingGet RatingGet Rating
KRGet RatingGet RatingGet Rating
CASYGet RatingGet RatingGet Rating
SFMGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

2 Best Stocks of All Time!

This bear market has me thinking back to my 2 best trades of all time. That being when I bought Amazon (AMZN) and Booking (BKNG) back in 2001 as they were tumbling down in the midst of a bear market...but now enjoying truly phenomenal gains. Let’s discuss what those investments had in common and how that will help us find more big winners in the years ahead. Read on below for more...

:  |  News, Ratings, and Charts

Bears Back in Charge...What Happens Next?

A month ago the bulls were claiming victory as they created a charge back over 4,000 for the S&P 500 (SPY). Since then that false narrative has been peeled away and investors are more honestly looking at the bleak outlook formed by high inflation and a hawkish Fed. That explains why we are back retesting the June lows. Now we have to ponder what comes next and how to trade our way to profits. Read on below for the full story...

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

:  |  News, Ratings, and Charts

Cut These 2 Stocks From Your Portfolio Right Now

The Fed succeeding in a ‘soft landing’ seems unlikely. Analysts are expecting a recession soon. So, with the rising odds of the Fed raising rates aggressively, it could be wise to steer clear of fundamentally weak stocks Roblox (RBLX) and Affirm Holdings (AFRM). Read on…

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

Read More Stories

More Costco Wholesale Corporation (COST) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All COST News